Clinical Trial Update: Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) [Phase 1, Phase 2]

View source ↗

Summary

Prospective randomized study (PROMETHEUS) evaluating mesenchymal stem cell therapy in patients undergoing cardiac surgery; trial phases 1 and 2 were terminated …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Ventricular Dysfunction

Drugs mentioned

• Mesenchymal stem cell therapy (mesenchymal stem cells)

Snippet

Sponsor: Joshua M Hare | Conditions: Stem Cell Transplantation, Ventricular Dysfunction, Left | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2015-04-02